methandrostenolone has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bombi, J; Bruguera, M; Camacho, L; Hernandez-Nieto, L; Rozman, C | 1 |
| Feagler, JR; Hartmann, JR; Johnson, FL; Lerner, KG; Majerus, PW; Siegel, M; Thomas, ED | 1 |
2 other study(ies) available for methandrostenolone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone).
Topics: Adult; Carcinoma, Hepatocellular; Hemoglobinuria, Paroxysmal; Humans; Liver Neoplasms; Male; Methandrostenolone | 1977 |
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.
Topics: Adolescent; Adult; Anabolic Agents; Androgens; Anemia, Aplastic; Carcinoma, Hepatocellular; Child, Preschool; Fanconi Syndrome; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Methandrostenolone; Methyltestosterone; Oxymetholone; Prednisone; Radionuclide Imaging; Testosterone | 1972 |